Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease

NCT01752790 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The study will be part of a European multicenter trial (Infliximab Top-down Study in Kids with Crohn's disease)

Conditions

Interventions

Sponsor

University of Roma La Sapienza